世界における前立腺がんワクチンの治験動向...市場調査レポートについてご紹介

1. Introduction to Prostate Cancer Vaccine

2. Mechanism of Prostate Cancer Vaccine

3. Global Prostate Cancer Vaccine Market Dynamics
3.1 Favorable Market Parameters
3.2 Marketing & Commercialization Challenges

4. Global Prostate Cancer Vaccine Market Outlook
4.1 Current Market Scenario
4.2 Global Prostate Cancer Vaccines Pipeline Overview

5. Global Prostate Cancer Vaccine Market Future Prospects

6. Personalized Cancer Vaccine Market Opportunities

7. Global Prostate Cancer Vaccines Clinical Trial Insight by Company, Country & Phase
7.1 Research
7.2 Preclinical
7.3 Phase-I
7.4 Phase-I/II
7.5 Phase-II
7.6 Phase-III

8. Marketed Prostate Cancer Vaccines by Company & Country

9. Suspended & Discontinued Prostate Cancer Vaccines in Clinical Trials
9.1 No Development Reported
9.2 Discontinued
9.3 Suspended

10. Competitive Landscape
10.1 Adamis Pharmaceuticals
10.2 Aduro BioTech
10.3 Bellicum Pharmaceuticals
10.4 CytoVac
10.5 Dendreon Corporation
10.6 Generex Biotechnology Corporation
10.7 Immunovaccine
10.8 Oncbiomune
10.9 Progenics
10.10 Sotio

Figure 1-1: Functions of Prostate Gland
Figure 1-2: Factors Responsible for Increasing Prostate Cancer Incidences
Figure 1-3: Different Methods of Prostate Cancer Treatment
Figure 2-1: Mechanism of Cancer Vaccines
Figure 2-2: Classification of Cancer Vaccines
Figure 2-3: Benefits of Prostate Cancer Vaccines
Figure 3-1: Drivers for Prostate Cancer Vaccines Market
Figure 3-2: Challenges for Prostate Cancer Vaccines Market
Figure 4-1: Prostate Cancer Vaccines Pipeline by Phase (%)
Figure 4-2: Prostate Cancer Vaccines Pipeline by Phase (Number of Drugs)
Figure 4-3: No Development Reported in Prostate Cancer Vaccines Pipeline by Phase (%)
Figure 4-4: No Development Reported in Prostate Cancer Vaccines Pipeline by Phase (Number of Drugs)
Figure 4-5: Discontinued Prostate Cancer Vaccines Pipeline by Phase (%)
Figure 4-6: Discontinued Prostate Cancer Vaccines Pipeline by Phase (Number of Drugs)
Figure 4-7: Suspended Prostate Cancer Vaccines Pipeline by Phase (%)
Figure 4-8: Suspended Prostate Cancer Vaccines Pipeline by Phase (Number of Drugs)
Figure 6-1: Personalized Cancer Vaccines Development Process
Figure 6-2: Personalized Cancer Vaccine Development Methodology
Figure 6-3: Skin Implant for Cancer Vaccine
Figure 10-1: Adamis Pharmaceuticals Pipeline
Figure 10-2: Bellicum Pharmaceuticals Pipeline
Figure 10-3: cytovac Pipeline
Figure 10-4: Generex Biotechnology Clinical Pipeline Overview
Figure 10-5: Immunovaccine Clinical Pipeline Overview

Table 6-1: Different Types of Biomarkers For Personalized Cancer Vaccine Development